Jab1 Interacts Directly with HIF-1α and Regulates Its Stability
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor-1 (HIF-1) is a master transcription factor that controls transcriptional activation of a number of genes responsive to the low cellular oxygen tension, including vascular endothelial growth factor (VEGF), erythropoietin, and glycolytic enzymes. The stability and activity of HIF-1alpha are regulated by binding to various proteins such as pVHL, p53, and p300/CBP. Here, using the yeast two-hybrid screening system, we found that HIF-1alpha interacts with Jab1 (Jun activation domain-binding protein-1), which is a coactivator of AP-1 transcription factor and fifth subunit of COP9 signalosome complex. The interaction of Jab1 with HIF-1alpha was confirmed by GST pull-down assay and also reproduced in vivo in HEK 293 cells, where endogenous Jab1 was coimmunoprecipitated with the overexpressed HIF-1alpha. Moreover, Jab1-enhanced transcriptional activity of HIF-1 under hypoxia led to increase the expression of VEGF, a major HIF-1 target gene. Furthermore, Jab1 increased HIF-1alpha protein levels, which was due to the enhanced HIF-1alpha stability. The binding of HIF-1alpha and p53 tumor suppressor protein, negative regulator of HIF-1alpha stability, was interfered in a Jab1-dependent manner. Taken together, these results indicate that Jab1 should be considered as a novel regulator of HIF-1alpha stability via direct interaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![FIG. 3 Jab1 increases HIF-1 𝛂 stability in response to hypoxia. A , HEK 293 cells were transfected with indicated expression vector and left untreated or exposed to 1% O 2 for 5 h. HIF-1 𝛂 protein levels by Western blot from protein extracts were examined ( top two panels ). Reverse transcriptase-PCR analysis ( bottom two panels ) was performed using specific primer for HIF-1 𝛂 and 𝛃 -actin. Lanes 1 and 3 , empty vector-transfected cells; lanes 2 and 4 , Jab1-transfected cells. B , the empty vector-transfected cells and Jab1-transfected cells were exposed for 5 h to 1% O 2 and followed by the addition of 100 𝛍 M cycloheximide ( CHX ) for 30 min in 1% O 2 . Cell lysates were harvested and subjected to immunoblot analysis of HIF-1 𝛂 . C , HEK 293 cells transfected with pBOS-HIF-1 𝛂 and pCMV-Jab1 ( open circles ) or pCMV alone ( closed circles ) were pulsed with [ 35 S]methionine and then chased for 0.5, 1, and 2 h under hypoxia. Cell lysates were immunoprecipitated with anti-HIF-1 𝛂 antibody. The intensity of HIF-1 𝛂 signals was quantified and plotted.](https://figures.cochat.ai/paper-figures/ae9eea1b6c574695bb9ba85cc2d6d293/jab1-interacts-directly-with-hif-1-and-regulates-its-stability-figure-3.png)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was observed that loss of p53 tumor suppressor gene in certain types of tumors is associated with elevated levels of HIF-1α40.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed Central · Cited by 1,230
Oxygen sensing and molecular adaptation to hypoxia
Bunn, H. F., & Poyton, R. O. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.839 · Cited by 1,172
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Tanimoto, K., Makino, Y., Pereira, T., & Poellinger, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4298 · Cited by 928
Stabilization of wild-type p53 by hypoxia-inducible factor 1α
An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., & Neckers, L. M. (1998) · Nature · doi:10.1038/32925 · Cited by 827
An essential role for p300/CBP in the cellular response to hypoxia
Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12969 · Cited by 790
Research works printed but not linked: 1
- 9. Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., and Livingston, D. M. (1996) J. Biol. Chem. 93, 12969-12973
Cited by
HIF-1α pathway: role, regulation and intervention for cancer therapy
Masoud, G. N., & Li, W. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.05.007 · Cited by 1,871
Hypoxia-Inducible Factor-1 (HIF-1)
Ke, Q., & Costa, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027029 · Cited by 1,646
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135
Integration of Oxygen Signaling at the Consensus HRE
Wenger, R. H., Stiehl, D. P., & Camenisch, G. (2005) · Science's STKE · doi:10.1126/stke.3062005re12 · Cited by 1,032
The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis: Figure 1
Greijer, A. E., & van der Wall, E. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.015032 · Cited by 784
Laccases: structure, reactions, distribution
Claus, H. (2004) · Micron · doi:10.1016/j.micron.2003.10.029 · Cited by 734
Regulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation
Jeong, J.-W., Bae, M.-K., Ahn, M.-Y., Kim, S.-H., Sohn, T.-K., Bae, M.-H., Yoo, M.-A., Song, E. J., Lee, K.-J., & Kim, K.-W. (2002) · Cell · doi:10.1016/s0092-8674(02)01085-1 · Cited by 716
Self-citationThe use of cobalt chloride as a chemical hypoxia model
Muñoz‐Sánchez, J., & Chánez‐Cárdenas, M. E. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3749 · Cited by 530
“For example, p53 promotes Mdm2‐mediated ubiquitination and degradation of HIF‐1α (Ravi et al., 2000), whereas Jab1, a transcriptional coactivator of c‐Jun and JunD, interacts directly with HIF‐1α, increasing its stability, possibly through competition with p53 (Bae et al., 2002).”
BackgroundWei, N., & Deng, X. W. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.111301.112449 · Cited by 491
“…(Chauchereau et al. 2000) SRC-1, steroid receptor coactivator p53, tumor suppressor (Bech-Otschir et al. 2001) HIF-1α, hypoxia-inducible factor-1 (Bae et al. 2002) Smad4, TGF-β signaling pathway common effector (Wan et al. 2002) HPO, hepatopoietin (Lu et al. 2002) TRC8, RING-finger membrane…”
HIF-1 and HIF-2 Transcription Factors - Similar but Not Identical
Loboda, A., Jozkowicz, A., & Dulak, J. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0067-2 · Cited by 477
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
Albadari, N., Deng, S., & Li, W. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1613370 · Cited by 351
Semenza, G. L. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.69 · Cited by 297
Hypoxia-inducible Factor and Its Biomedical Relevance
Huang, L. E., & Bunn, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200030200 · Cited by 315
Reciprocal influence of the p53 and the hypoxic pathways
Sermeus, A., & Michiels, C. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.48 · Cited by 265
The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses
Bracken, C. P., Whitelaw, M. L., & Peet, D. J. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2370-y · Cited by 251
C5L2, a Nonsignaling C5A Binding Protein
Okinaga, S., Slattery, D., Humbles, A., Zsengeller, Z., Morteau, O., Kinrade, M. B., Brodbeck, R. M., Krause, J. E., Choe, H.-R., Gerard, N. P., et al. (2003) · Biochemistry · doi:10.1021/bi034489v · Cited by 261
Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational modifications
Brahimi-Horn, C., Mazure, N., & Pouysségur, J. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.04.010 · Cited by 214
HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels
Masson, N., & Ratcliffe, P. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00655 · Cited by 215
“For FIH itself, recently solved crystallographic structures show a dimeric structure that conforms to the predicted βbarrel jelly-roll conformation (Bae et al., 2002; Dann et al., 2002; Hewitson et al., 2002).”
BackgroundMaternal Adaptation to High-altitude Pregnancy: An Experiment of Nature—A Review
Moore, L. G., Shriver, M., Bemis, L., Hickler, B., Wilson, M., Brutsaert, T., Parra, E., & Vargas, E. (2004) · Placenta · doi:10.1016/j.placenta.2004.01.008 · Cited by 210
“ARD1 [136] Cul2, JAB1/CSN5, RBX1 [137–139] PHD1, 2, 3 [140,141] VHL [7,142]”
Hypoxia‐inducible factor‐1 and oncogenic signalling
Bárdos, J. I., & Ashcroft, M. (2004) · BioEssays · doi:10.1002/bies.20002 · Cited by 206
Targeted genes and interacting proteins of hypoxia inducible factor-1.
Liu, W., Shen, S. M., Zhao, X., & Chen, G. Q. (2012) · Europe PMC (PubMed Central) · Cited by 249
Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
Singh, D., Arora, R., Kaur, P., Singh, B., Mannan, R., & Arora, S. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0190-2 · Cited by 166
“Undoubtedly, loss of p53 in the tumor is associated with the enhanced level of HIF-1α expression [52].”
BackgroundConstitutive and inducible expression and regulation of vascular endothelial growth factor
Xie, K., Wei, D., Shi, Q., & Huang, S. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.04.003 · Cited by 163
“[188] Bae MK, Ahn MY, Jeong JW, Bae MH, Lee YM, Bae SK, et al.”
BackgroundYasinska, I. M., & Sumbayev, V. V. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00807-x · Cited by 156
HIF-1: master and commander of the hypoxic world
Mazure, N. M., Brahimi-Horn, M. C., Berta, M., Benizri, E. I., Bilton, R. L., Dayan, F., Ginouvès, A., Berra, E., & Pouysségur, J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.022 · Cited by 181
JAB1/CSN5: a new player in cell cycle control and cancer
Shackleford, T. J., & Claret, F. X. (2010) · Cell Division · doi:10.1186/1747-1028-5-26 · Cited by 159
“This domain does not, however, appear to be critical to Jab1/CSN5’s functions outside of the full CSN, such as the stabilization of HIF-1a and its role as a co-factor for E2F1 apoptotic function [9,22].”
BackgroundInfluentialSpeer, R. E., Karuppagounder, S. S., Basso, M., Sleiman, S. F., Kumar, A., Brand, D., Smirnova, N., Gazaryan, I., Khim, S. J., & Ratan, R. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.026 · Cited by 155
“This can be overcome by Jun activation domain-binding protein-1, which was previously known as a coactivator of the AP-1 transcription factor before it was shown to activate HIF-1 transcriptional activity by interfering with p53 binding to HIF-1 [67].”
BackgroundMultiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice
Tomoda, K., Yoneda‐Kato, N., Fukumoto, A., Yamanaka, S., & Kato, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406559200 · Cited by 168
Schwechheimer, C. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.023 · Cited by 154
Kato, J., & Yoneda‐Kato, N. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01349.x · Cited by 141
“…al. 2006 RUNX3 Runt-related transcription factor 3 Kim et al. 2009 WNVCp West Nile Virus Capsid protein Oh et al. 2006b HIF-1a Hypoxia inducible transcription factor Bae et al. 2002; Bemis et al. 2004 Smad7 TGF-b signal transducer Kim et al. 2004 Smad4 TGF-b signal transducer Wan et al. 2002 PGP9.”
BackgroundCommon Molecular Mechanisms of Mammary Gland Development and Breast Cancer
Lundgren, K., Holm, C., & Landberg, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7390-6 · Cited by 157
S100 proteins and their influence on pro-survival pathways in cancer
Emberley, E. D., Murphy, L. C., & Watson, P. H. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-052 · Cited by 140
“1996), HIF-1 (Bae et al. 2002), NF-kB (Dechend et al.”
Monzon, F. A., Alvarez, K., Peterson, L. E., Truong, L. D., Amato, R. J., Hernandez-McClain, J., Tannir, N. M., Parwani, A. V., & Jonasch, E. W. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.107 · Cited by 145
“33 Interestingly, it has been shown that COPS5 regulates HIF1α activity by direct interaction and modulation of its stability”
Macrophage Migration Inhibitory Factor Activates Hypoxia-Inducible Factor in a p53-Dependent Manner
Oda, S., Oda, T., Nishi, K., Takabuchi, S., Wakamatsu, T., Tanaka, T., Adachi, T., Fukuda, K., Semenza, G. L., & Hirota, K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002215 · Cited by 129
“Bae et al. reported that Jab1 (coactivator of c-Jun, also known as the CSN5 subunit of the COP9 signalosome) interfered with the binding of HIF-1α to the p53 tumor suppressor protein and thereby increased HIF-1α protein levels by enhancing HIF-1α stability in HEK293 cells”
BackgroundInfluence of Inflammatory Cytokines on Arteriogenesis
BUSCHMANN, I., HEIL, M., JOST, M., & SCHAPER, W. (2003) · Microcirculation · doi:10.1038/sj.mn.7800199 · Cited by 123
A compendium of proteins that interact with HIF-1α
Semenza, G. L. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.041 · Cited by 115
“HSP70 331–427 CHIP [64] HSP90 81–200 [65] Importin 7 bHLH-PAS-A [66] ING1b ING ND [67] IRF1 ND [68] JAB1 COPS5, CSN5 401–603 [69] JMJD2C KDM4C 575–786 [70] KAT5 TIP60 ND [71] KDM1A LSD1 ND [72,73] KSHV LANA 300–530 [74] KSHV vIRF ND [75] LAMP2A ND HSC70 [62] MAX ND [76] MCM2 ND [77] MCM3 531–826 [77] MCM5 ND [77] MCM7…”
Hypoxia-induced angiogenesis in human hepatocellular carcinoma
Kim, K.-R., Moon, H.-E., & Kim, K. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0380-0 · Cited by 122
“Recently our laboratory reported a new role of Jab1 in regulating HIF-1α protein stability by competition with p53, and leading to HIF-1 dependent transcriptional activation [ 107 ].”
BackgroundSelf-citationKouvaraki, M. A., Rassidakis, G. Z., Tian, L., Kumar, R., Kittas, C. N., & Claret, F.-X. (2003) · PubMed · Cited by 117
Kim, B.-C., Lee, H.-J., Park, S. H., Lee, S. R., Karpova, T. S., McNally, J. G., Felici, A., Lee, D. K., & Kim, S.-J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2251-2262.2004 · Cited by 110
HIF‐1α protein as a target for S‐nitrosation
Sumbayev, V. V., Budde, A., Zhou, J., & Brüne, B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03887-5 · Cited by 108
HIF-1α: a Valid Therapeutic Target for Tumor Therapy
Hong, S., Lee, H., & Kim, K. (2004) · Cancer Research and Treatment · doi:10.4143/crt.2004.36.6.343 · Cited by 125
Self-citationS100A7 and the progression of breast cancer
Emberley, E. D., Murphy, L. C., & Watson, P. H. (2004) · Breast Cancer Research · doi:10.1186/bcr816 · Cited by 107
“Effects could impact on survival, such as through an enhanced HIF-1 [40] and hypoxia response, or could possibly be mediated through other Jab1 downstream pathways such as Bcl-3 [41,42] and its effect on NF-κB.”
BackgroundThe Emerging Role of the COP9 Signalosome in Cancer
Richardson, K. S., & Zundel, W. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0233 · Cited by 101
“p53 (86) Unknown Unknown Yes Yes HIF-1a (32, 49) Degraded Stabilized Yes Yes c-jun (58) Unknown Unknown Yes Yes JunD (58) Unknown Unknown Yes Yes SMAD4 (45) Unknown Degraded Yes Yes SMAD7 (44) Stabilized Degraded Unknown Yes ID1 (88) Unknown Unknown Unknown Yes ID3 (88) Unknown Unknown Unknown Yes Estrogen receptor a…”
BackgroundThe hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1
Tanaka, Y., Kanai, F., Ichimura, T., Tateishi, K., Asaoka, Y., Guleng, B., Jazag, A., Ohta, M., Imamura, J., Ikenoue, T., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209093 · Cited by 98
“…expressed Jab1 was also reported to be associated with protein ubiquitination and degradation, including that of p27 (Tomoda et al., 1999), HIF 1a (Bae et al., 2002), and TGFb (Wan et al., 2002), the coexpression of HBx and Jab1 did not result in these or similar functions (data not shown).”
BackgroundPsoriasin interacts with Jab1 and influences breast cancer progression.
Emberley, E. D., Niu, Y., Leygue, E., Tomes, L., Gietz, R. D., Murphy, L. C., & Watson, P. H. (2003) · PubMed · Cited by 96
Hypoxia and HIF-1 activation in bacterial infections
Devraj, G., Beerlage, C., Brüne, B., & Kempf, V. A. J. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.11.003 · Cited by 101
S-nitrosylation of thioredoxin mediates activation of apoptosis signal-regulating kinase 1
Sumbayev, V. V. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00199-1 · Cited by 95
Hsieh, Y., Su, I., Wang, H.-C., Tsai, J.-H., Huang, Y., Chang, W., Lai, M.-D., Lei, H.-Y., & Huang, W. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0098 · Cited by 89
The Hypoxia-Inducible Factor and Tumor Progression Along the Angiogenic Pathway
Brahimi-Horn, M. C., & Pouysségur, J. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)42004-x · Cited by 99
The von Hippel–Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis
Barry, R. E., & Krek, W. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.008 · Cited by 86
Hwang, C. Y., Ryu, Y. S., Chung, M.-S., Kim, K. D., Park, S. S., Chae, S., Chae, H. Z., & Kwon, K. (2004) · Oncogene · doi:10.1038/sj.onc.1208116 · Cited by 78
“Jab1 also interacts with hypoxia-inducible factor1a (HIF-1a) and enhances its stability, leading to increased expression of vascular endothelial growth factor, a major HIF-1a target, under hypoxic conditions (Bae et al., 2002).”
BackgroundSelf-citationTomoda, K., Kato, J., Tatsumi, E., Takahashi, T., Matsuo, Y., & Yoneda‐Kato, N. (2004) · Blood · doi:10.1182/blood-2004-04-1242 · Cited by 76
Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response
Lee, Y.-H., Judge, A., Seo, D., Kitade, M., Gómez-Quiroz, L. E., Ishikawa, T., Andersen, J. B., Kim, B.-K., Marquardt, J. U., Raggi, C., et al. (2011) · Oncogene · doi:10.1038/onc.2011.126 · Cited by 74
“In particular, CSN5 seems to act as a transcriptional coactivator for MYC, which is essential for the transcriptional activation of genes involved in cell proliferation, angiogenesis and cell invasion (Claret et al., 1996; Bae et al., 2002; Adler et al., 2006).”
BackgroundSelf-citationCSN5 Isopeptidase Activity Links COP9 Signalosome Activation to Breast Cancer Progression
Adler, A. S., Littlepage, L. E., Lin, M., Kawahara, T. L. A., Wong, D. J., Werb, Z., & Chang, H. Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3060 · Cited by 72
“Most relevant to cancer are the interactions with hypoxia-inducible factor-1a (HIF-1a), leading to HIF-1a protein stabilization and increased angiogenic activity ( 26 , 27), and E2F1, leading to selective activation of E2F1-mediated apoptotic activity (28).”
BackgroundHsu, M., Huang, C., Chang, H., Hu, T., & Hung, W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5040 · Cited by 70
Esteva, F. J., Şahin, A. A., Rassidakis, G. Z., Yuan, L. X. H., Smith, T. L., Yang, Y., Gilcrease, M. Z., Cristofanilli, M., Nahta, R., Pusztai, L., et al. (2003) · PubMed · Cited by 70
Distinct aerobic and hypoxic mechanisms of HIF-α regulation by CSN5
Bemis, L., Chan, D. A., Finkielstein, C. V., Qi, L., Sutphin, P. D., Chen, X., Stenmark, K., Giaccia, A. J., & Zundel, W. (2004) · Genes & Development · doi:10.1101/gad.1180104 · Cited by 71
“Thus, CSN5 was found to positively regulate HIF function and to be physically associated with the HIF-1 complex, supporting a previous CSN5–HIF-1 interaction found in a yeast two-hybrid study (Bae et al. 2002).”
The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL in a common pathway
Gemmill, R. M., Bemis, L., Lee, J. P., Sözen, M. A., Barón, A. E., Zeng, C. X., Erickson, P. F., Hooper, J. E., & Drabkin, H. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205437 · Cited by 69
“To date, we have not detected changes in VHL, HIF-1a, JAB1, Cul2 or its NEDD8 modi®ed form or p27Kip1 in HEK 293 cells transiently transfected with TRC8 expression constructs.”
BackgroundInfluentialCrosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer
Dekker, Y., Dévédec, S. E. L., Danen, E. H. J., & Liu, Q. (2022) · Genes · doi:10.3390/genes13091585 · Cited by 72
Kang, H. J., Kim, H. J., Rih, J.-K., Mattson, T. L., Kim, K. W., Cho, C., Isaacs, J. S., & Bae, I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513033200 · Cited by 74
Self-citationEssential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair
Tian, L., Peng, G., Parant, J. M., Leventaki, V., Drakos, E., Zhang, Q., Parker‐Thornburg, J., Shackleford, T. J., Dai, H., Lin, S.-Y., et al. (2010) · Oncogene · doi:10.1038/onc.2010.345 · Cited by 66
“, 2006), HIF-1 alpha (Bae et al., 2002), and Smad4/7 (Wan et al.”
BackgroundFunctional genomics approach to hypoxia signaling
Seta, K. A., & Millhorn, D. E. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00836.2003 · Cited by 68
The interaction between HIF-1 and AP-1 transcription factors in response to low oxygen
Laderoute, K. R. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.03.005 · Cited by 69
Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target
Zhan, L., Huang, C., Meng, X., Song, Y., Wu, X. Q., Yang, Y., & Li, J. (2014) · Biochimie · doi:10.1016/j.biochi.2014.10.013 · Cited by 63
Yun, H.-M., Baik, J., Kang, I., Jin, C., & Rhim, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068759 · Cited by 61
Kim, I.-W., Peng, X.-H., Sauna, Z. E., FitzGerald, P. C., Xia, D., Müller, M., Nandigama, K., & Ambudkar, S. V. (2006) · Biochemistry · doi:10.1021/bi060308o · Cited by 57
Emberley, E. D., Alowami, S. O., Snell, L., Murphy, L. C., & Watson, P. H. (2004) · Breast Cancer Research · doi:10.1186/bcr791 · Cited by 59
“Studies in cell lines suggest that Jab1 is involved in diverse interactions with components of cell signaling pathways [26,28-34].”
BackgroundInhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo
Asare, Y., Ommer-Bläsius, M., Azombo, F. A., Alampour‐Rajabi, S., Sternkopf, M., Sanati, M., Gijbels, M. J., Schmitz, C., Sinitski, D., Tilstam, P. V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618411114 · Cited by 62
Liu, G., Claret, F. X., Zhou, F., & Pan, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00135 · Cited by 64
Shackleford, T. J., Zhang, Q. C., Tian, L., Vu, T. T., Korapati, A. L., Baumgartner, A. M., Le, X., Liao, W. S. ‐., & Claret, F. X. (2011) · Breast Cancer Research · doi:10.1186/bcr2902 · Cited by 57
“It can also interact with several important intracellular signaling molecules including hypoxia inducible factor-1 alpha (HIF-1a), macrophage migration inhibitory factor (MIF), E2F1, and cullin 1 (CUL-1) [11,12].”
BackgroundKim, J. H., Kim, J. H., Yu, Y., Shin, J. Y., Lee, H. ‐., & Kim, K.-C. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00243.x · Cited by 56
Self-citationPan, S., Zhang, T., Rong, Z., Li, H., Gu, Z., Wu, Q., Dong, S., Liu, Q., Lin, Z., Deutschová, L., et al. (2017) · Molecular Ecology · doi:10.1111/mec.14090 · Cited by 55
“…genes could potentially induce apoptosis (Arany et al. 1996; Rolfs et al. 1997; Tan & Hagen 2013; Yu et al. 2009; Mo et al. 2012; Zhu et al. 2016; Bae et al. 2002; Wang et al. 2013; Jiang et al. 2015; Liu et al. 2007; Lichner et al. 2012; Yuan et al. 2010; Santos et al. 1998; Xiang et al. 2010;…”
BackgroundKaweme, N. M., Zhou, S., Changwe, G. J., & Zhou, F. (2020) · Biomarker Research · doi:10.1186/s40364-020-00242-z · Cited by 54
Lee, E., Yim, S., Lee, S.-K., & Park, H. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15067-9 · Cited by 39
Yu, B., Miao, Z., Jiang, Y., Li, M.-H., Yang, N. Y., Li, T., & Ding, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0808 · Cited by 51
Estrogen receptor determination and long term survival of patients with carcinoma of the breast.
Crowe, J. P., Gordon, N. H., Hubay, C. A., Shenk, R. R., Zollinger, R. M., Brumberg, D. J., Wl, M., & Shuck, J. M. (1991) · PubMed · Cited by 64
Nishimoto, A., Kugimiya, N., Hosoyama, T., Enoki, T., Li, T., & Hamano, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.105 · Cited by 51
Goto, A., Niki, T., Moriyama, S., Funata, N., Moriyama, H., Nishimura, Y., Tsuchida, R., Kato, J., & Fukayama, M. (2004) · Pathology International · doi:10.1111/j.1440-1827.2004.01679.x · Cited by 47
Regulation of Egr-1 by association with the proteasome component C8
Bae, M.-H., Jeong, C., Kim, S., Bae, M., Jeong, J., Ahn, M., Bae, S., Kim, N. D., Kim, C. W., Kim, K.-R., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00310-5 · Cited by 46
Self-citationThe emerging roles of Jab1/CSN5 in cancer
Wang, L., Zheng, J., & Pei, D. (2016) · Medical Oncology · doi:10.1007/s12032-016-0805-1 · Cited by 46
Zakharova, E. T., Kostevich, V. A., Av, S., & Vasilyev, V. B. (2012) · BioMetals · doi:10.1007/s10534-012-9586-y · Cited by 45
“Chelators of Fe, Cu b Zn Baker (1994) Armstrong et al.”
BackgroundIOP1, a novel hydrogenase-like protein that modulates hypoxia-inducible factor-1α activity
Huang, J., Song, D., Flores, A., Zhao, Q., Mooney, S. M., Shaw, L. M., & Lee, F. S. (2007) · Biochemical Journal · doi:10.1042/bj20060635 · Cited by 46
Kasper, L. H., & Brindle, P. K. (2005) · Cell Cycle · doi:10.4161/cc.5.2.2353 · Cited by 47
The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer
Guo, Z., Wang, Y., Zhao, Y., Shu, Y., Liu, Z., Zhou, H., Wang, H., & Zhang, W. (2018) · Gene · doi:10.1016/j.gene.2018.11.061 · Cited by 44
The histone deacetylase HDAC1 activates HIF1α/VEGFA signal pathway in colorectal cancer
Chen, C., Meng, W., Wang, C., Sun, D., Liu, P., Zhong, X., He, Q., & Yu, W. (2020) · Gene · doi:10.1016/j.gene.2020.144851 · Cited by 51
Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice
Turtzo, L. C., Li, J., Persky, R., Benashski, S. E., Weston, G. K., Bucala, R., Venna, V. R., & McCullough, L. D. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.016 · Cited by 43
“ANOVA analysis of variance COXIV cytochrome c oxidase CSN5 COP9 signalsome subunit 5; alternative name for JAB1 E2 estrogen ELISA enzyme-linked immunosorbent assay HIF-1α hypoxia-inducible factor-1α Iba1 ionized calcium binding adaptor molecule 1 IHC immunohistochemistry IL-1β interleukin-1β IL-6 interleukin-6 JAB1 Ju…”
BackgroundNew Insights into the Genetic Basis of Monge’s Disease and Adaptation to High-Altitude
Stobdan, T., Akbari, A., Azad, P., Zhou, D., Poulsen, O., Appenzeller, O., Gonzales, G. F., Telenti, A., Wong, E., Saini, S., et al. (2017) · Molecular Biology and Evolution · doi:10.1093/molbev/msx239 · Cited by 48
“Furthermore, the CMS group and only one population, New Insights into the Genetic Basis of Monge’s Disease . doi:10.1093/molbev/msx239 MBE that is, PEL (Peruvians from Lima, Peru), had a frequency of 12%, while the frequency in the global populations was <10% (fig.”
InfluentialExperimental evidence for cancer resistance in a bat species
Hua, R., Ma, Y.-S., Yang, L., Hao, J., Hua, Q., Shi, L., Yao, X., Zhi, H.-Y., & Liu, Z. (2024) · Nature Communications · doi:10.1038/s41467-024-45767-1 · Cited by 41
Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression
Satija, S., Kaur, H., Tambuwala, M. M., Sharma, P., Vyas, M., Khurana, N., Sharma, N., Bakshi, H. A., Charbe, N. B., Zacconi, F. C. M., et al. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210120154929 · Cited by 40
Villar, D., Ortiz-Barahona, A., Gómez-Maldonado, L., Pescador, N., Sánchez-Cabo, F., Hackl, H., Rodriguez, B. A. T., Trajanoski, Z., Dopazo, A., Huang, T. H. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045708 · Cited by 36
“[87,88], a protein originally identified as a transcriptional coactivator for AP1 [89].”
BackgroundTorales‐Cardeña, A., Martínez-Torres, I., Rodríguez–Martínez, S., Gómez‐Chávez, F., Cancino‐Díaz, J. C., Vázquez-Sánchez, E. A., & Cancino-Diaz, M. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/607363 · Cited by 218
“In this review, the role of HIF-1𝛼 in the cross talk between the cytokines and cells of the immunological system involved in the pathogenesis of psoriasis is discussed.”
BackgroundDey, P., Velázquez‐Villegas, L. A., Faria, M., Turner, A. P. F., Jonsson, P., Webb, P., Williams, C., Gustafsson, J.-Å., & Ström, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128239 · Cited by 41
“Recently, several studies have found that HIF-1α protein can be stabilized without a decrease in oxygen tension by factors interfering with oxygen-dependent HIF-1α degradation [22–24].”
BackgroundResultCharacterization of ARD1 variants in mammalian cells
Kim, S., Park, J. A., Kim, J. H., Lee, J., Seo, J. H., Jung, B., Chun, K., Jeong, J., Bae, M., & Kim, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.018 · Cited by 39
Self-citationRepressors of photomorphogenesis
Kim, T.-N., Kim, B.-N., & von Arnim, A. G. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)20006-6 · Cited by 40
Jab1 as a Mediator of Nuclear Export and Cytoplasmic Degradation of p53
Lee, E., Oh, W., & Song, J. (2006) · Molecules and Cells · doi:10.1016/s1016-8478(23)17401-2 · Cited by 42
When hypoxia signalling meets the ubiquitin-proteasomal pathway, new targets for cancer therapy
Brahimi‐Horn, C., & Pouysségur, J. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.003 · Cited by 41
Rapid Two-Step Synthesis of Mitrin from Heparosan: A Replacement for Heparin
Kuberan, B., Beeler, D. L., Lawrence, R., Lech, M., & ROSENBERG, R. D. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036737g · Cited by 38
Kozhukhar, A. V., Yasinska, I. M., & Sumbayev, V. V. (2005) · Biochimie · doi:10.1016/j.biochi.2005.09.007 · Cited by 37
Yasinska, I. M., Kozhukhar, A. V., & Sumbayev, V. V. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.06.004 · Cited by 37
Hypoxia-Inducible Factors: Post-translational Crosstalk of Signaling Pathways
Dimova, E. Y., & Kietzmann, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-738-9_13 · Cited by 37
Metadata
- Authors
- Bae, M.-K., Ahn, M.-Y., Jeong, J.-W., Bae, M.-H., Lee, Y. M., Bae, S.-K., Park, J.-W., Kim, K.-R., & Kim, K.-W.
- Affiliations
- Pusan National University (KR)
- Seoul National University (KR)
- Corresponding author
- Kim, Kyu-Won
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 277
- Issue
- 1
- Pages
- 9-12
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1989183186
- Cited by
- 196
- References
- 25
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 6 · 2014: 6 · 2013: 8 · 2012: 6
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6854 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- Jab1, HIF-1α, HIF-1, protein stability, protein-protein interaction, COP9 signalosome, p53, vascular endothelial growth factor, transcriptional coactivator, hypoxia, AP-1
- MeSH terms
- COP9 Signalosome Complex, Binding, Competitive, Cells, Cultured, DNA-Binding Proteins, Humans, Peptide Hydrolases, Transcription Factors, Transcription, Genetic, Up-Regulation, Tumor Suppressor Protein p53, Intracellular Signaling Peptides and Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.